Company Overview

PRIME exits and American HealthCare Capital are pleased to exclusively introduce a cosmetic and reconstructive surgery practice for sale in New York. The business operates from two affluent metropolitan locations and features an accredited in-house surgical suite, enabling high-margin, private-pay procedures with exceptional patient privacy and convenience.

Services Overview

The practice delivers a comprehensive portfolio of surgical services including body contouring, breast surgery, and facial aesthetics, alongside a robust lineup of minimally invasive treatments such as injectables and fillers. Approximately 90% of revenue is derived from private, cash-pay patients, minimizing reimbursement risk and ensuring predictable cash flow. The brand benefits from a sterling reputation, longstanding patient relationships, and consistent media recognition, resulting in a steady stream of referrals and repeat clientele.

Financial Overview

In 2024, the practice generated $1.38 million in revenue and $403,000 in adjusted EBITDA (29%). The first half of 2025 has produced $850,000 in revenue and $313,000 in adjusted EBITDA, with full-year projections of $1.7 million revenue and $626,000 in adjusted EBITDA (37%). The business is well-positioned for continued growth through expanded marketing, additional providers, and service line extensions.

The owner is a highly regarded, dual board-certified plastic surgeon is offering a premier cosmetic and reconstructive surgery practice for acquisition. This is a rare opportunity to acquire a top-tier, cash-heavy plastic surgery practice with strong brand equity in a high-demand market. Purchase price will also include the capital value of medical and operating room equipment, including a novel liposuction laser, which totals to approximately $500,000

Asking Price

The asking price for this opportunity is $2.5 million.